Fig. 4 | Scientific Reports

Fig. 4

From: The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen

Fig. 4

Dose‒response relationship between the PLR and OS in MM patients from the RCS analysis. The odds ratios (the red line) and 95% confidence intervals (the area between the red dashed lines) were based on the RCS for the natural log-transformed PLR (PLR-ln) with 3 knots. The DS stage, ISS stage, sex, Hb, Plt, ALB, LDH, RDW_SD, age, Cr, Ca, β2-MG, proportion of bone marrow monoclonal plasma cells and transplantation status were adjusted in the model.

Back to article page